Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Arbutus Biopharma Corp (ABUS) common shares are the subject of a reported beneficial ownership position held by Nomura Global Financial Products, Inc., a wholly owned subsidiary of Nomura Holdings, Inc. The two entities report beneficial ownership of 14,512,000 shares, or 7.3%, with shared voting and dispositive power; each reports zero sole voting and dispositive power. The 7.3% calculation uses 199,275,907 common shares outstanding as of September 30, 2026.
Key Figures
Beneficially owned shares:14,512,000 sharesPercentage of class:7.3%Common shares outstanding:199,275,907 shares
3 metrics
Beneficially owned shares14,512,000 sharesReported by Nomura Global Financial Products, Inc.; Nomura Holdings, Inc. may be deemed to beneficially own the same shares.
Percentage of class7.3%Based on 199,275,907 common shares outstanding as of September 30, 2026.
Common shares outstanding199,275,907 sharesAs of September 30, 2026; used to calculate the reported percentage of class.
Key Terms
beneficially own, Shared Voting Power, Shared Dispositive Power
3 terms
beneficially ownregulatory
"may be deemed to beneficially own the common shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Shared Voting Powerregulatory
"Shared Voting Power 14,512,000.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Powerregulatory
"Shared Dispositive Power 14,512,000.00"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many ABUS shares does Nomura report beneficially owning?
Nomura Global Financial Products, Inc. reports beneficial ownership of 14,512,000 ABUS common shares, and its parent, Nomura Holdings, Inc., may be deemed to beneficially own those same shares. The reported position represents 7.3% of the class.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Arbutus Biopharma Corp
(Name of Issuer)
Common Shares, without par value
(Title of Class of Securities)
03879J100
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
03879J100
1
Names of Reporting Persons
NOMURA HOLDINGS INC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
JAPAN
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
14,512,000.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
14,512,000.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
14,512,000.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.3 %
12
Type of Reporting Person (See Instructions)
HC
Comment for Type of Reporting Person: (1) Shared voting and dispositive power represents 14,512,000 common shares beneficially owned by Nomura Global Financial Products, Inc. ("NGFP"). NGFP is a wholly owned subsidiary of Nomura Holdings, Inc., which accordingly may be deemed to beneficially own the common shares beneficially owned by NGFP.
(2) The percent of class is calculated based on 199,275,907 common shares outstanding as of September 30, 2026, as reported in the Issuer's quarterly report on Form 10-Q for the fiscal quarter ended September 30, 2026 filed with the SEC on November 10, 2026.
SCHEDULE 13G
CUSIP Number(s):
03879J100
1
Names of Reporting Persons
NOMURA GLOBAL FINANCIAL PRODUCTS INC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
14,512,000.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
14,512,000.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
14,512,000.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.3 %
12
Type of Reporting Person (See Instructions)
BD
Comment for Type of Reporting Person: (3) The percent of class is calculated based on 199,275,907 common shares outstanding as of September 30, 2026, as reported in the Issuer's quarterly report on Form 10-Q for the fiscal quarter ended September 30, 2026 filed with the SEC on November 10, 2026.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Arbutus Biopharma Corp
(b)
Address of issuer's principal executive offices:
701 Veterans Circle, Warminster, PA 18974
Item 2.
(a)
Name of person filing:
Nomura Holdings, Inc.
Nomura Global Financial Products, Inc.
This Schedule 13G excludes securities beneficially owned, if any, by certain subsidiaries of Nomura Holdings Inc. whose beneficial ownership of securities are disaggregated from that of Nomura Holdings Inc. in accordance with SEC Release No. 34-39538 (January 12, 1998).
(b)
Address or principal business office or, if none, residence:
Nomura Holdings, Inc.:
13-1, Nihonbashi 1-chome, Chuo-ku, Tokyo 103-8645, Japan
Nomura Global Financial Products, Inc.:
Worldwide Plaza
309 West 49th Street
New York, NY 10019
(c)
Citizenship:
Nomura Holdings, Inc.:
Japan
Nomura Global Financial Products, Inc.:
Delaware
(d)
Title of class of securities:
Common Shares, without par value
(e)
CUSIP Number(s):
03879J100
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Items 5-11 of the cover pages are incorporated by reference.
(b)
Percent of class:
Items 5-11 of the cover pages are incorporated by reference.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Items 5-11 of the cover pages are incorporated by reference.
(ii) Shared power to vote or to direct the vote:
Items 5-11 of the cover pages are incorporated by reference.
(iii) Sole power to dispose or to direct the disposition of:
Items 5-11 of the cover pages are incorporated by reference.
(iv) Shared power to dispose or to direct the disposition of:
Items 5-11 of the cover pages are incorporated by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See Exhibit B
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
NOMURA HOLDINGS INC
Signature:
/s/ Samir Patel
Name/Title:
Samir Patel, Managing Director
Date:
11/16/2026
NOMURA GLOBAL FINANCIAL PRODUCTS INC
Signature:
/s/ Samir Patel
Name/Title:
Samir Patel, Authorized Officer
Date:
11/16/2026
Exhibit Information
Exhibit A - Joint Filing Agreement
Exhibit B - Subsidiaries